Finance

Beta
Lists
CLSDQ:OTCMKTS
Clearside Biomedical, Inc
$0.29
0.00%
(0.00) 1D
Jun 11, 3:52:43 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLSDQ...
Mkt. cap
1.49M
Avg. vol.
4.88K
Volume
82.00
52-wk high
$1.37
52-wk low
$0.01
EPS
-$5.06
Beta
1.76
Shares outstanding
5.23M
No. of employees
32
Mkt. cap
1.49M
Avg. vol.
4.88K
Volume
82.00
52-wk high
$1.37
52-wk low
$0.01
EPS
-$5.06
Beta
1.76
Shares outstanding
5.23M
No. of employees
32
News stories
From sources across the web
About Clearside Biomedical, Inc
CEO-
Employees32
Founded2011
HeadquartersAlpharetta, Georgia, United States
SectorPharmaceutical industry
Websiteclearsidebio.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
306.00K
2.33M
492.00K
201.00K
Cost of goods sold
149.00K
248.00K
-
-
Cost of revenue
149.00K
248.00K
-
-
Research and development expenses
4.24M
4.46M
1.58M
2.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.06M
2.82M
2.48M
4.31M
Operating expense
7.31M
7.29M
4.06M
7.24M
Total operating expenses
7.46M
7.54M
4.06M
7.24M
Operating income
-7.15M
-5.20M
-3.57M
-7.04M
Other non operating income
2.06M
207.00K
1.72M
3.57M
EBT including unusual items
-7.31M
-7.51M
-4.50M
-5.97M
EBT excluding unusual items
-7.31M
-7.51M
-4.50M
-5.97M
Income tax expense
-
715.00K
-
-
Effective tax rate
-
-9.52%
-
-
Other operating expenses
-
-
-
-
Net income
-7.31M
-8.22M
-4.50M
-5.97M
Net profit margin
-2,387.58%
-352.92%
-913.62%
-2,971.14%
Earnings per share
-1.50
-1.65
-0.06
-1.14
Interest and investment income
358.00K
163.00K
115.00K
65.00K
Interest expense
-2.58M
-2.67M
-2.76M
-2.57M
Net interest expenses
-2.22M
-2.51M
-2.65M
-2.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.07M
-5.12M
-3.48M
-6.96M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer